Malignant neoplasm of urachus
ICD-10 C67.7 is a billable code used to indicate a diagnosis of malignant neoplasm of urachus.
Malignant neoplasm of the urachus is a rare type of cancer that arises from the urachus, a remnant of the embryonic allantois that connects the bladder to the umbilicus. This neoplasm is classified under urinary tract malignancies and is often associated with other bladder cancers. The urachus is located in the anterior abdominal wall, and tumors can present as either adenocarcinomas or other histological types. Symptoms may include hematuria, abdominal pain, and urinary obstruction. Diagnosis typically involves imaging studies such as ultrasound, CT scans, or MRI, followed by biopsy for histological confirmation. Staging of urachal cancer is crucial for determining treatment options and prognosis, often following the AJCC (American Joint Committee on Cancer) staging system. Surgical management is the primary treatment modality, which may include partial or total cystectomy, depending on the extent of the disease. Adjuvant therapies such as chemotherapy or radiation may be considered based on the tumor's characteristics and staging.
Detailed surgical notes, pathology reports, imaging studies, and staging information.
Diagnosis and management of urachal tumors, surgical interventions, and follow-up care.
Urologists must ensure comprehensive documentation of tumor characteristics and staging to support accurate coding.
Treatment plans, chemotherapy regimens, and follow-up assessments.
Management of advanced urachal cancer, including chemotherapy and palliative care.
Oncologists should document the rationale for treatment choices and any adjuvant therapies used.
Performed for urachal cancer with extensive disease.
Operative report detailing the procedure and findings.
Urologists must document the extent of disease and any lymph node involvement.
Common symptoms include hematuria, abdominal pain, and urinary obstruction. Patients may also present with nonspecific symptoms that can delay diagnosis.